In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping

ConditionDrug Allergy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14+
SponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

About this trial

Testing a clinical decision tool (BL-Predictor)

Eligibility criteria

Qualifiers

signed informed consnet

Disqualifiers

Use of immunomodulators, antihistamines and corticosteroids

Trial design

Treatments tested in this trial

  • BL-Predicter

Treatment groups

332 Participants
are divided into 2 treatment groups

Locations

This trial has no locations